Atherosclerosis by Virus Infection-A Short Review

Area of Science:

• Cardiovascular Science
• Infectious Disease
• Pathology

Background:

• Atherosclerosis, characterized by arterial plaque buildup, is a major cardiovascular disease risk factor.
• While traditional risk factors include smoking and hypertension, infections are increasingly recognized as contributors.
• Viruses such as influenza, herpes, hepatitis, papillomaviruses, and SARS-CoV-2 are implicated in atherosclerosis development.

Purpose of the Study:

• To review viruses associated with atherosclerosis development.
• To elucidate the viral characteristics and pathogenic mechanisms involved.
• To summarize current therapeutic strategies, including vaccines and antiviral treatments.

Main Methods:

• Literature review of scientific articles and research papers.
• Analysis of viral characteristics and their role in atherogenesis.
• Synthesis of information on disease mechanisms and treatment options.

Main Results:

• Several prevalent viruses are linked to the development of atherosclerosis.
• Viral infections can trigger inflammatory and immune responses contributing to plaque formation.
• COVID-19 patients frequently exhibit cardiovascular complications, suggesting viral impact.

Conclusions:

• Viral infections represent a significant, often overlooked, cause of atherosclerosis.
• Understanding viral mechanisms is crucial for developing targeted prevention and treatment strategies.
• Further research into antiviral therapies and vaccines is warranted for managing virus-associated cardiovascular disease.